Bigul

Updates on ensuing Board Meeting on May 30, 2015

Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2015 for which necessary intimation has already been given, will also interalia consider the matter for Allotment of 36,89,200 warrants convertible in to equal number of Equity shares on preferential basis to the promoters / promoters' group and persons other than the promoters / promoters' group pursuant to the...
28-05-2015
Bigul

Board to consider Dividend

Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May May 30, 2015, inter alia, to approve audited financial result for the quarter /year ended March 31, 2015 and for recommending dividend, if any.
25-05-2015
Bigul

Outcome of EGM

Lincoln Pharmaceuticals Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on May 15, 2015.
18-05-2015
Bigul

Scruttnizers Report

Lincoln Pharmaceuticals Ltd has submitted to BSE a copy of Consolidated Scrutinizer's report on Remote E-voting and Poll, Regarding EGM held on May 15, 2015, of the Company.
18-05-2015
Bigul

Cessation of Company Secretary

Lincoln Pharmaceuticals Ltd has informed BSE that Ms. Purva Arora, has tendered her resignation from the post of Company Secretary of the Company with effect from the closure of business hours on March 16, 2015.
27-04-2015
Bigul

EGM on May 15, 2015

Lincoln Pharmaceuticals Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on May 15, 2015.
21-04-2015
Bigul

Shareholding Pattern For March 31, 2015

Lincoln Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.
17-04-2015
Bigul

Outcome of Board Meeting (EGM on April 16, 2015)

Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 16, 2015, has subject to the approval of the shareholders of the Company at the Extra Ordinary General Meeting to be held on May 15, 2015 and stock exchanges where the shares of the Company are listed, considered and approved, issue of 36,89,200 convertible warrants on preferential basis at price of Rs. 82/- per warrant to the promoters...
16-04-2015
Bigul

Board Meeting on April 16, 2015

Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 16, 2015, to finalize the issue of convertible warrants on preferential basis to the Promoters/Promoters group and Non promoters also and further to decide about the date of Extra Ordinary general Meeting for obtaining approval of members of the Company for the preferential issue of convertible warrants.
13-04-2015
Bigul

Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Ashish R Patel & Rajnikant G Patel has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
23-03-2015
Next Page
Close

Let's Open Free Demat Account